Ireland· IE-PA-EU/1/01/173/003
Vaniqa 11.5%
A eflornithine product containing eflornithine, registered in Ireland by Almirall, S.A.. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Eflornithine is registered in 12 of 19 countries.
Countries holding a registration under ATC D11AX16 (eflornithine), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Eflornithine · ATC D11AX16
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Eflornithine
- Manufacturer
- Almirall, S.A.
- Country
- Ireland (IE)
- ATC code
- D11AX16
- ATC class
- Eflornithine
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/01/173/003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eflornithine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomVaniqa 11.5% creamDE Pharmaceuticals
- SpainVANIQA 11,5 % CREMAAlmirall S.A.
- SwitzerlandIfinwil 192 mg, TablettenNorgine AG
- CzechiaVANIQAAlmirall, S.A., Barcelona
- NorwayIwilfinUS WorldMeds
- PolandVaniqaAlmirall, S.A.
- SwedenVaniqa 11,5 % KrämAlmirall S.A.
- BelgiumVaniqa 11.5 %Almirall
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- France · Ornidyl
- Iceland · Vaniqa
- Liechtenstein · Vaniqa
- Norway · Vaniqa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/70120600-375f-42c6-8002-ee5c54c02dd2 GET /v1/drugs/70120600-375f-42c6-8002-ee5c54c02dd2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Cream",
"routes": [
"Cutaneous use"
],
"source": "hpra",
"atc_all": [
"D11AX",
"D11AX16"
],
"strength": null,
"pa_number": "EU/1/01/173/003",
"substances": [
"Eflornithine"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "28/03/2001",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about eflornithine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.